Details of the Drug

General Information of Drug (ID: DMFG8TI)

Drug Name
INCB00928
Indication
Disease Entry ICD 11 Status REF
Anemia 3A00-3A9Z Phase 2 [1]
Multiple myeloma 2A83 Phase 2 [1]
Myelodysplastic syndrome 2A37 Phase 2 [1]
Drug Type
Small molecular drug
Cross-matching ID
TTD ID
D50OLM
Repurposed Drugs (RPD) Click to Jump to the Detailed RPD Information of This Drug

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Activin receptor-like kinase 2 (ALK-2) TTJNBQA ACVR1_HUMAN Inhibitor [2]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

References

1 ClinicalTrials.gov (NCT04582539) To Assess the Safety and Tolerability of INCB000928 in Participants With Myelodysplastic Syndromes or Multiple Myeloma.. U.S. National Institutes of Health.
2 Clinical pipeline report, company report or official report of Incyte.